ABSTRACT
Introduction ............................................................................................................ 192 MET Structure, Biology, and Signaling in Normal Cells ...................................... 192 MET in Cancer Cells ............................................................................................. 195
MET in Renal Cell Cancer ................................................................................ 197 MET in Head and Neck Cancer ........................................................................200 MET in Lung Cancer ........................................................................................200 MET in Esophageal, Gastric, and GI Cancers .................................................. 201 MET in Breast Cancer .......................................................................................202
Cancer Therapeutics ...............................................................................................202 MET Antagonists ..............................................................................................202 Monoclonal Antibodies against MET/HGF ......................................................203
